loading

Finanzdaten der Avenue Therapeutics Inc-Aktie (ATXI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31
Periodenlänge 3 Monate
Research and Development
Operating Income/Loss
Nonoperating Income/Loss
Income/Loss From Continuing Operations Before Tax
Income/Loss From Continuing Operations After Tax
Net Income/Loss
Preferred Stock Dividends And Other Adjustments
Attributable To Noncontrolling Interest
Basic Average Shares
Basic Earnings Per Share
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
$29.83
price up icon 2.19%
$50.00
price up icon 3.14%
$102.92
price up icon 0.78%
$148.63
price down icon 0.43%
$144.48
price up icon 1.18%
ONC ONC
$323.87
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):